Dapiglutide

达匹格鲁肽

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameDapiglutide
Drug Alias NameZP-7570
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 2 receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucagon-like peptide 2 receptor
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesZealand Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesZealand Pharma A/S
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A